Partnership story

Archived content.

Pharmaceutical companies convene in New York


United Nations Secretary-General together with senior officials from the United Nations system met with seventeen of the world’s research-based and generic pharmaceutical and diagnostic companies.

Progress on strengthening efforts to expand access to HIV services in low- and middle-income countries was reviewed. This meeting held on 9th October 2008 was a follow-up to the last high-level dialogue between the UN and pharmaceutical and diagnostic companies in July 2006.

It was concluded that work to increase access to HIV prevention and treatment had contributed to the development of health care systems, but that more strengthening needed to happen. While this is primarily the responsibility of national governments, important efforts have already been made through partnerships with industry. However it was agreed that more could be done, especially to address shortages of the health workforce and improve managerial capacities. The Secretary-General highlighted the need for greater collaboration between the private sector and the UN to expand existing efforts in the spirit of goal 8 of the Millennium Development Goals on building a global partnership for development. He noted that progress on all fronts is essential in order to reverse the AIDS epidemic. As an outcome participants agreed to continue to hold periodic high-level meetings, under the leadership of UNAIDS, to take stock of progress and to identify new collaborative measures.